These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17327194)

  • 1. Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea.
    Juang P; Skledar SJ; Zgheib NK; Paterson DL; Vergis EN; Shannon WD; Ansani NT; Branch RA
    Am J Infect Control; 2007 Mar; 35(2):131-7. PubMed ID: 17327194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
    Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intravenous immunoglobulin in severe Clostridium difficile-associated diarrhea.
    Shahani L; Koirala J
    Hosp Pract (1995); 2015; 43(3):154-7. PubMed ID: 26189489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
    Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of Clostridium difficile-associated diarrhea in solid organ transplant patients.
    Gellad ZF; Alexander BD; Liu JK; Griffith BC; Meyer AM; Johnson JL; Muir AJ
    Transpl Infect Dis; 2007 Dec; 9(4):276-80. PubMed ID: 17635835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea.
    McPherson S; Rees CJ; Ellis R; Soo S; Panter SJ
    Dis Colon Rectum; 2006 May; 49(5):640-5. PubMed ID: 16525744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with clostridium difficile-associated disease.
    Das R; Feuerstadt P; Brandt LJ
    Am J Gastroenterol; 2010 Sep; 105(9):2040-9. PubMed ID: 20389295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of Clostridium difficile-associated disease at King Chulalongkorn Memorial Hospital, Thailand.
    Pupaibool J; Khantipong M; Suankratay C
    J Med Assoc Thai; 2008 Jan; 91(1):37-43. PubMed ID: 18386542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategies for C. difficile associated diarrhea.
    Stepan C; Surawicz CM
    Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective.
    Bajaj JS; Ananthakrishnan AN; Hafeezullah M; Zadvornova Y; Dye A; McGinley EL; Saeian K; Heuman D; Sanyal AJ; Hoffmann RG
    Am J Gastroenterol; 2010 Jan; 105(1):106-13. PubMed ID: 19844204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.
    Arango JI; Restrepo A; Schneider DL; Callander NS; Ochoa-Bayona JL; Restrepo MI; Bradshaw P; Patterson J; Freytes CO
    Bone Marrow Transplant; 2006 Mar; 37(5):517-21. PubMed ID: 16435018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe pseudomembranous colitis after moxifloxacin use: a case series.
    Gallagher JC; Du JK; Rose C
    Ann Pharmacother; 2009 Jan; 43(1):123-8. PubMed ID: 19066322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease.
    Neal MD; Alverdy JC; Hall DE; Simmons RL; Zuckerbraun BS
    Ann Surg; 2011 Sep; 254(3):423-7; discussion 427-9. PubMed ID: 21865943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis.
    Byrn JC; Maun DC; Gingold DS; Baril DT; Ozao JJ; Divino CM
    Arch Surg; 2008 Feb; 143(2):150-4; discussion 155. PubMed ID: 18283139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Past, present, and future therapies for Clostridium difficile-associated disease.
    Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
    Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin for resistant Clostridium difficile infection.
    Murphy C; Vernon M; Cullen M
    Age Ageing; 2006 Jan; 35(1):85-6. PubMed ID: 16303776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurrent Clostridium difficile enterocolitis].
    Bergamin B; Hess T; Jost R; Ballmer PE; Imoberdorf R
    Schweiz Med Wochenschr; 2000 Nov; 130(44):1681-4. PubMed ID: 11103440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
    Aseeri M; Schroeder T; Kramer J; Zackula R
    Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
    Kim YG; Graham DY; Jang BI
    J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile-associated diarrhea and chronic renal insufficiency.
    Yousuf K; Saklayen MG; Markert RJ; Barde CJ; Gopalswamy N
    South Med J; 2002 Jul; 95(7):681-3. PubMed ID: 12144071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.